Authors
Loading...
Expert consensus report highlights critical limitations of tumor EPR heterogeneity and patient translation, indicating the need to address mechanistic gaps in oncology nanomedicine.
Prabhakar et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: